|
|
|
Ethical Issues in International Biomedical Research is the definitive book on the ethics of research involving human subjects in developing countries. Using 21 actual case studies, it covers the most controversial topics, including the ethics of placebo research in Africa, what benefits should be provided to the community after completion of a research trial, how to address conflicts between IRBs in developed and developing countries, and undue inducement of poor people in developing countries. Each case is accompanied by two expert commentaries, written by many of the worlds leading experts in bioethics as well as new voices with research experience in developing countries. No other volume has this scope.
| ISBN | 0195179226 | | Pages | 368 | | ISBN13 | 9780195179224
(What's this?) | | Volumes | 1 | | Publisher | Oxford University Press Inc | | Weight (grammes) | 682 | | Imprint | Oxford University Press Inc | | Published in | New York | | Format | Hardback | | Height (mm) | 235 | | Publication date | 22 Mar 2007 | | Width (mm) | 156 | | Library of Congress | 2006043751 | | Spine width (mm) | 22 | | DEWEY | 174.28 | | Academic level | Undergraduate, Postgraduate, Professional / Scholarly | | DEWEY edition | DC22 | |
|
| |
| Pt. I | | Collaborative partnership | | | | Case 1 | | Community involvement in biodiversity prospecting in Mexico | | 21 | | Commentary 1.1 | | Private and public knowledge in the debate on bioprospecting : implications for local communities and prior informed consent by Brent Berlin and Elois A. Berlin | | 26 | | Commentary 1.2 | | Politics, risk, and community in the Maya ICBG case by Fern Brunger and Charles Weijer | | 35 | | Case 2 | | Selling genes | | 43 | | Commentary 2.1 | | What might Tonga learn from Iceland? by James Till and David L. Tritchler | | 46 | | Commentary 2.2 | | Whose DNA? : Tonga and Iceland, biotech, ownership, and consent by Lopeti Senituli and Margaret Boyes | | 53 | | Case 3 | | Sustainability of a fluoride varnish feasibility study in Nicaragua | | 64 | | Commentary 3.1 | | Sustainability and obligations to the community in the Nicaragua floride varnish pilot study : the investigator's perspective by Martin Hobdell | | 67 | | Commentary 3.2 | | Assessing the sustainability of the Nicaragua fluoride varnish study by Florencia Luna | | 71 | | Pt. II | | Social value | | | | Case 4 | | Malarone testing in pregnant women in Thailand | | 79 | | Commentary 4.1 | | Proposed phase 3 trials of Malarone in pregnancy are unethical by Juntra Karbwang | | 82 | | Commentary 4.2 | | A phase 3 trial of Malarone in pregnancy as a pubic good by Janis Lazdins | | 84 | | Case 5 | | Neglected diseases : incentives to conduct research in developing countries | | 87 | | Commentary 5.1 | | Drug development for visceral leishmaniasis : a failure of the market and public policy by James Orbinski and Solomon Benatar | | 90 | | Commentary 5.2 | | Bringing innovations for diseases of poverty to market : the case of paromomycin for visceral leishmaniasis by Hannah Kettler | | 97 | | Pt. III | | Scientific validity | | | | Case 6 | | Evaluating home-based treatment strategies for neonatal sepsis in India | | 105 | | | More... | | |
This is a well-written book and a must-read for anyone trying to understand the concerns associated with international biomedical research. The cases address research in many parts of the world on different disorders and conditions. The commentaries give readers a better appreciation of the breadth and depth of the relevant ethical issues. Doody's Notes  Be the first to write a customer review
|
|
|
|
|
Enlarge
